Hereford x Angus cows (n = 36; initial wt 568+/-59 kg) were used to evaluate the effects of undegradable intake protein (UIP) supplementation on plasma hormone and metabolite concentrations. Treatments were control (unsupplemented) or one of three protein supplements. Supplements were fed at 1.3 kg DM/d and included UIP at low, medium, or high levels (53, 223, or 412 g UIP/kg supplement DM, respectively). Supplements were formulated to be isocaloric (1.77 Mcal NEm/kg) and to contain equal amounts of degradable intake protein (DIP; 211 g DIP/kg supplement DM). Prairie hay (5.8% CP) was offered for ad libitum consumption. Jugular blood samples were collected daily from each cow during six 7-d collection periods (corresponding to mo 7, 8, and 9 of gestation and to mo 1, 2, and 3 of lactation). Plasma glucose concentrations were similar between control and supplemented cows during mo 2 and 3 of lactation; however, the low UIP treatment group had consistently higher plasma glucose (P< or =.02) than cows fed medium or high UIP supplements during gestation and the last month of lactation. During gestation, cows fed the high UIP supplement had higher (P< or =.08) plasma glucose than cows fed the medium UIP supplement. During gestation, plasma insulin concentration was increased (P = .01) by supplementation; insulin also increased (P<.01; mo 8 and 9) as supplemental UIP increased. During lactation, plasma insulin was greater (P = .01) in supplemented than in control cows. During mo 2 and 3 of lactation, insulin was lower (P< or =.04) in cows fed low UIP supplement compared with cows fed medium or high UIP supplements. Growth hormone concentration was higher (P< or =.03) in control cows than in supplemented cows in all periods measured except mo 7 of gestation. Plasma nonesterified fatty acid concentrations were higher (P< or =.03) in control cows than in supplemented cows in all periods measured except the 1st mo of lactation. These data are interpreted to suggest that protein supplementation and level of UIP can alter plasma concentrations of hormones and metabolites in gestating and lactating beef cows consuming low-quality hay.
Hereford x Angus cows (n = 36; initial wt = 568+/-59 kg) were used to evaluate effects of undegradable intake protein (UIP) supplementation on forage utilization and performance of beef cows fed low-quality hay. Treatments were control (unsupplemented) or one of three protein supplements. Supplements were fed at 1.3 kg DM/d and included UIP at low, medium, or high levels (53, 223, or 412 g UIP/kg supplement DM, respectively). Supplements were formulated to be isocaloric (1.77 Mcal NEm/kg) and to contain equal amounts of degradable intake protein (DIP; 211 g DIP/kg supplement DM). Intake of forage was measured daily during six 7-d collection periods, which approximated mo 7, 8, and 9 of gestation and mo 1, 2, and 3 of lactation. Prairie hay (5.8% CP) was offered daily for ad libitum consumption. Cows were weighed and condition-scored on d 7 of each period. Supplemented cows had greater (P = .01) total organic matter intake (g/kg BW) compared with control animals during gestation. Forage organic matter intake (g/kg BW) was greater (P< or =.02) for control cows than for supplemented cows during lactation. Digestion of OM and NDF was lower (P<.10) for control than for supplemented cows. Body weight of supplemented cows was greater (P = .01) than that of control cows on four of six weigh dates. Supplemental UIP did not affect (P> .10) cow body weight or condition score. Body condition scores of supplemented cows were higher (P = .02) during mo 9 of gestation and during mo 3 of lactation compared with controls. Reproductive performance was similar (P>.10) among treatment groups, and there were few differences in calf performance. These data were interpreted to suggest that supplemental protein can increase total tract OM and NDF digestion by beef cows and increase body weight. Increasing the level of UIP in the supplement had little effect on forage utilization or animal performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.